1. Home
  2. ADTN vs NBTX Comparison

ADTN vs NBTX Comparison

Compare ADTN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$16.68

Market Cap

1.2B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
NBTX
Founded
1985
2003
Country
United States
France
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
ADTN
NBTX
Price
$16.68
$39.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$15.50
$36.00
AVG Volume (30 Days)
2.7M
75.3K
Earning Date
05-04-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
N/A
EPS
N/A
N/A
Revenue
$1,083,807,000.00
N/A
Revenue This Year
$11.09
$58.17
Revenue Next Year
$8.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.46
N/A
52 Week Low
$7.11
$4.10
52 Week High
$19.98
$57.14

Technical Indicators

Market Signals
Indicator
ADTN
NBTX
Relative Strength Index (RSI) 53.96 48.15
Support Level $8.45 $38.89
Resistance Level $18.34 $41.89
Average True Range (ATR) 1.14 3.32
MACD 0.15 -1.31
Stochastic Oscillator 43.03 6.08

Price Performance

Historical Comparison
ADTN
NBTX

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: